ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.8332-1_8487+146dup

dbSNP: rs2137596319
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001356937 SCV001552238 pathogenic not provided no assertion criteria provided clinical testing The BRCA2 c.8332-?_8632+?dup variant (chr13.hg19.g.32944559-?_32945161+?dup) results in a duplication of exons 19 and 20, although the precise breakpoints of this duplication were not determined, nor were the effects of this variant on the resulting mRNA or protein product determined. The variant was identified in 3 of 4418 proband chromosomes (frequency: 0.001) from individuals or families with breast or ovarian cancer (Caux-Moncoutier 2011, de la Hoya 2006, Walsh 2006), and was also identified in HGMD and UMD (2X as a causal variant). The variant is predicted to cause a frameshift, which alters the protein's amino acid sequence and leads to a premature stop codon, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the BRCA2 gene are an established mechanism of disease in hereditary breast and ovarian cancer and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.